Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 ProteinKathleen Aertgeerts, Satoshi Sogabe, R.J. Skene et al.|Journal of Biological Chemistry|2011Cited by 441
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-<i>d</i>]pyrimidine ScaffoldTomoyasu Ishikawa, Keiji Kamiyama, Toshiya Tamura et al.|Journal of Medicinal Chemistry|2011Cited by 223
Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancerTomohiro Kaku, Akihiro Tasaka, Takenori Hitaka et al.|Bioorganic & Medicinal Chemistry|2011Cited by 126
Design and synthesis of novel pyrimido[4,5-b]azepine derivatives as HER2/EGFR dual inhibitorsYouichi Kawakita, Tomoyasu Ishikawa, Masaki Seto et al.|Bioorganic & Medicinal Chemistry|2013Cited by 79
C17,20-lyase inhibitors. Part 2: Design, synthesis and structure–activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C17,20-lyase inhibitorsNobuyuki Matsunaga, Akihiro Tasaka, Tomohiro Kaku et al.|Bioorganic & Medicinal Chemistry|2004Cited by 56